Clinical trial
Randomized On-X Anticoagulation Trial
NCT00291525 · On-X Life Technologies, Inc., Industry · Completed
Key facts
| NCT number | NCT00291525 |
|---|---|
| Title | Randomized On-X Anticoagulation Trial |
| Official title | Prospective Randomized On-X Anticoagulation Clinical Trial (PROACT) |
| Acronym | PROACT |
| Lead sponsor | On-X Life Technologies, Inc., Industry |
| Collaborators | Clinipace Worldwide Industry Acelis Connected Health WCG IRB Avania |
| Status | Completed |
| Study type | Interventional |
| Conditions | Heart Valve Disease |
| Intervention type | Device |
| Interventions | On-X valve using reduced anticoagulation, On-X Valve with Standard warfarin Therapy |
| Enrollment | 977 |
| Start date | Jun 6, 2006 |
| Primary completion | Aug 8, 2023 |
| Completion | Dec 29, 2023 |
| First posted | Feb 14, 2006 |
| Last update posted | Dec 24, 2024 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: